Owners and management
CVR: 46657136
Secondary names: Genesis Biopharma DK ApS
Not available
Genesis Pharma (Cyprus) Limited (100%)
CVR · view owners
Alexandros Jacovides, Constantinos Evripides
CVR · view management
Active
Founded 9 July 2026
CVR · view overview
No headcount reported
Name registered: Genesis Biopharma Denmark ApS
CVR · 09/07/2026
View the full event history
Genesis Biopharma Denmark ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2026. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The management consists of Alexandros Jacovides and Constantinos Evripides. The company is owned by Genesis Pharma (Cyprus) Limited.
Selskabets formål er at levere: a. markedsføring og salg af farmaceutiske produkter; b. tjenesteydelser inden for lovgivning, lægemiddelovervågning og medicinske anliggender; samt andre supplerende supporttjenester til understøttelse af forretningsaktiviteterne (markedsføring, salg og distribution af farmaceutiske produkter).
No annual financial figures are available for this company.
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringThe CVR number of Genesis Biopharma Denmark ApS is 46657136.
Genesis Biopharma Denmark ApS is owned by Genesis Pharma (Cyprus) Limited.
The management of Genesis Biopharma Denmark ApS consists of Alexandros Jacovides and Constantinos Evripides.
Genesis Biopharma Denmark ApS was founded on 9 July 2026.
Genesis Biopharma Denmark ApS is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n. (industry code 749990).
Genesis Biopharma Denmark ApS is located at c/o TMF Denmark A/S, H.C. Andersens Boulevard 38 3. th, 1553 København V.
Claim this page to add your logo and social links. Free to get started.
As of July 9, 2026, Alexandros Jacovides is registered as director of Genesis Biopharma Denmark ApS.
As of July 9, 2026, Constantinos Evripides is registered as director of Genesis Biopharma Denmark ApS.
As of July 9, 2026, is registered as an owner of Genesis Biopharma Denmark ApS with an ownership share of 100%.
Genesis Biopharma Denmark ApS was founded on July 9, 2026.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Companies in the same industry and area
CVR 46473493
CVR 40813233
CVR 45548198
CVR 32741150
CVR 13589003
